相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligand
Junhui Yu et al.
CANCER GENE THERAPY (2021)
Chemopreventive effect of α-hederin/carboplatin combination against experimental colon hyperplasia and impact on JNK signaling
Hoda Bahr et al.
TOXICOLOGY MECHANISMS AND METHODS (2021)
Discovery of New Apoptosis-Inducing Agents for Breast Cancer Based on Ethyl 2-Amino-4,5,6,7-Tetra Hydrobenzo[b]Thiophene-3-Carboxylate: Synthesis, In Vitro, and In Vivo Activity Evaluation
Emad M. Gad et al.
MOLECULES (2020)
Triaryl dicationic DNA minor -groove binders with antioxidant activity and induce in breast cancer
Mohamed S. Nafie et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
Synthesis, characterization of some pyrazine derivatives as anti-cancer agents: In vitro and in Silico approaches
Eman S. Tantawy et al.
JOURNAL OF MOLECULAR STRUCTURE (2020)
Discovery of hydrazide-based pyridazino[4,5-b]indole scaffold as a new phosphoinositide 3-kinase (PI3K) inhibitor for breast cancer therapy
Ahmed A. M. Sarhan et al.
RSC ADVANCES (2020)
Synthesis, molecular modeling and anti-cancer evaluation of a series of quinazoline derivatives
Ahmed Khodair et al.
CARBOHYDRATE RESEARCH (2019)
Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer
Yi Qu et al.
NATURE CHEMICAL BIOLOGY (2018)
Drug resistance induces the upregulation of H2S-producing enzymes in HCT116 colon cancer cells
Ashley A. Untereiner et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Laser-responsive liposome for selective tumor targeting of nitazoxanide nanoparticles
Wael M. Darwish et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Nitazoxanide, an antiprotozoal drug, inhibits late-stage autophagy and promotes ING1-induced cell cycle arrest in glioblastoma
Xiaoxiong Wang et al.
CELL DEATH & DISEASE (2018)
PMP22 Regulates Self-Renewal and Chemoresistance of Gastric Cancer Cells
Wangyu Cai et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Apoptotic pathways as a therapeutic target for colorectal cancer treatment
Aman M. Abraha et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer
Wojciech Senkowski et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Chemoresistance to doxorubicin induces epithelial-mesenchymal transition via upregulation of transforming growth factor signaling in HCT116 colon cancer cells
Jinpeng Li et al.
MOLECULAR MEDICINE REPORTS (2015)
Drug repurposing in oncology-patient and health systems opportunities
Francesco Bertolini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
A functional perspective of nitazoxanide as a potential anticancer drug
Nicola Di Santo et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2014)
The way Wnt works: Components and mechanism
Kenyi Saito-Diaz et al.
GROWTH FACTORS (2013)
A c-Myc Activation Sensor-Based High-Throughput Drug Screening Identifies an Antineoplastic Effect of Nitazoxanide
Hua Fan-Minogue et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Research Perspective: Potential Role of Nitazoxanide in Ovarian Cancer Treatment. Old Drug, New Purpose?
Nicola Di Santo et al.
Cancers (2013)
Nitazoxanide suppresses IL-6 production in LPS-stimulated mouse macrophages and TG-injected mice
Seong Keun Hong et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Inhibition of JAK2/STAT3 signalling induces colorectal cancer cell apoptosis via mitochondrial pathway
Wan Du et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Inflammation and Colon Cancer
Janos Terzic et al.
GASTROENTEROLOGY (2010)
Generation of Mice with a Conditional Null Allele for Wntless
April C. Carpenter et al.
GENESIS (2010)
Wnt/Fz signaling and the cytoskeleton: potential roles in tumorigenesis
Shih-Lei Lai et al.
CELL RESEARCH (2009)
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
Bryan T. MacDonald et al.
DEVELOPMENTAL CELL (2009)
Wnt signaling pathways meet Rho GTPases
Karni Schlessinger et al.
GENES & DEVELOPMENT (2009)
Thiazolides inhibit growth and induce glutathione-S-transferase Pi (GSTP1)-dependent cell death in human colon cancer cells
Joachim Mueller et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Nitazoxanide - A review of its use in the treatment of gastrointestinal infections
Vanessa R. Anderson et al.
DRUGS (2007)
Aberrant Wnt/β-catenin signaling can induce chromosomal instability in colon cancer
Michel V. Hadjihannas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Thermodynamics of β-catenin-ligand interactions -: The roles of the N- and C-terminal tails in modulating binding affinity
HJ Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Deregulated GSK3β activity in colorectal cancer:: Its association with tumor cell survival and proliferation
A Shakoori et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Wnt and calcium signaling:: β-Catenin-independent pathways
AD Kohn et al.
CELL CALCIUM (2005)
The Wnt antagonist DICKKOPF-1 gene is a downstream target of β-catenin/TCF and is downregulated in human colon cancer
JM Gonzálex-Sancho et al.
ONCOGENE (2005)
The Wnt/β-catenin signaling pathway targets PPARγ activity in colon cancer cells
EÅ Jansson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
MUC1 and nuclear β-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis
SE Baldus et al.
CLINICAL CANCER RESEARCH (2004)
The glamour and gloom of glycogen synthase kinase-3
RS Jope et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Pharmacological inhibitors of glycogen synthase kinase 3
L Meijer et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth
M Mazor et al.
ONCOGENE (2004)
GSK3 inhibitors: Development and therapeutic potential
P Cohen et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Role of glycogen synthase kinase-3 in TNF-α-induced NF-κB activation and apoptosis in hepatocytes
RF Schwabe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
KP Hoeflich et al.
NATURE (2000)
The Wnt/Ca2+ pathway -: a new vertebrate Wnt signaling pathway takes shape
M Kühl et al.
TRENDS IN GENETICS (2000)
分享论文
